Cargando…
Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease
OBJECTIVE: This study aimed to determine the most appropriate cognitive and cerebrospinal fluid (CSF) biomarker setting to distinguish frontotemporal dementia (FTD) from Alzheimer’s disease (AD). METHOD: Patients with FTD, those with AD, and those without dementia were enrolled in this study. CSF am...
Autores principales: | Casoli, Tiziana, Paolini, Susy, Fabbietti, Paolo, Fattoretti, Patrizia, Paciaroni, Lucia, Fabi, Katia, Gobbi, Beatrice, Galeazzi, Roberta, Rossi, Roberto, Lattanzio, Fabrizia, Pelliccioni, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833432/ https://www.ncbi.nlm.nih.gov/pubmed/31524025 http://dx.doi.org/10.1177/0300060519860951 |
Ejemplares similares
-
Diagnostic performance of new and classic CSF biomarkers in age-related dementias
por: Marchegiani, Francesca, et al.
Publicado: (2019) -
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018) -
Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021) -
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012) -
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)